Coloplast A/S

Profitability for 1 year: -11.65%
Dividend yield: 3.17%
Sector: Healthcare

Coloplast A/S

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
5.61 40.78 -86.24% 14.93 -62.41%
P/S 0.73 3.94 -81.4%
P/BV 1.19 3.63 -67.21%
P/FCF 3.82 27.47 -86.08%
Ev/Ebitda 5.26 16.62 -68.38%
Ev/S 1.57 4.28 -63.29%
Ev/FCF 8.21 34.7 -76.35%
E/P 0.18 1.09 -83.55%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
29.91 23.31 28.29% 30.95 -3.38%
ROE 21.2 13.9 52.54%
ROA 7.07 7.42 -4.73%
ROIC 24.19 14.44 67.56%
ROS 13.05 11.36 14.9%
ROCE 40.71 16.96 139.99%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
5/10
2.89 2.82 2.47% 2.71 +6.49%
Nеt Debt/Ebitda 2.77 0.031 8819.26%
Debt/Ratio 0.47 0.21 122.4%
Debt/Equity 2 1.06 88.89%
Debt/Net Income 6.62 8.7 -23.84%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
7.93/10
3.17 1.67 90.04% 2.49 +27.23%
Number of years of dividend growth 2 1.59 25.81%
DSI 0.93 0.77 21.2%
Average dividend growth 5.68 -341.02 -101.67%
Average percentage for 5 years 2.49 3.17 -21.3%
Average percentage for payments 67.44 146.26 -53.89%
Difference from average difference in sector 1.5

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
35.15 219.8 -84.01%
Growth impulse Ebitda in 5 years 8.56 199.85 -95.72%
Growth impulse Net Income in 5 years -29.02 156.25 -118.57%
Growth impulse FCF in 5 years 51.29 140.47 -63.49%
Growth impulse EPS in 5 years 310.74 269.86 15.15%
IP Score
6.71/10

Similar companies

Sinopharm Group Co., Ltd.

Alibaba Health Information Technology Limited

Chugai Pharmaceutical Co., Ltd.

Roche Holding

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription